TRANSFER 10000 IU INJECTION

Transfer 10000IU Injection contains active ingredients like Recombinant human erythropoietin Alfa/Ep. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication helps treat anemia due to chronic kidney diseases (CKD), as well as cancer chemotherapy or HIV treatment using zidovudine. It also decreases the need for transfusions of red blood cells for patients at risk of losing blood due to surgery planned and other therapies.
Transfer 10000IU injections should not be used by patients who have excessive hypertension or one of the components thereof active thrombotic microangiopathy (TMA) and purified red cell aplasia (PRCA) uncontrolled seizures and pregnancy or lactation. It is also recommended to use it carefully in patients with a history of blood clots, heart disease, kidney disease,e, stroke, liver diseases, thalassemia, sickle-cell anemia, myelodysplastic syndrome, leukemia or c, or cancer. It is not recommended for use by children under 18 in cases where the benefits are more significant than the risks. Older patients must be monitored closely for any adverse effects. Before you begin this treatment, you must speak with your doctor regarding the potential risks and advantages of Transfer 10000IU injection.